CompletedPhase 3NCT02443246

A Prospective, Multi-center Study to Evaluate the Efficacy and Safety of Vitamin D3 B.O.N. Intramuscular Injection in Adults With Vitamin D Deficiency

Studying Disorders of vitamin D metabolism

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Kwang Dong Pharmaceutical co., ltd.
Principal Investigator
Sung-Kil Lim, Professor
Severance Hospital Seoul, Korea
Intervention
Vitamin D3 B.O.N. Injection (cholecalciferol 200,000IU)(drug)
Enrollment
84 target
Eligibility
19-65 years · All sexes
Timeline
20142015

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02443246 on ClinicalTrials.gov

Other trials for Disorders of vitamin D metabolism

Additional recruiting or active studies for the same condition.

See all trials for Disorders of vitamin D metabolism

← Back to all trials